Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hirschbichler, ST; Erro, R; Ganos, C; Stamelou, M; Batla, A; Balint, B; Bhatia, KP.
"Atypical" atypical parkinsonism: Critical appraisal of a cohort.
Parkinsonism Relat Disord. 2017; 37: 36-42.
Doi: 10.1016/j.parkreldis.2016.12.006
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Hirschbichler Stephanie
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Atypical parkinsonian conditions such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal syndrome (CBS) and Dementia with Lewy bodies (DLB) comprise 10-15% of parkinsonian syndromes. Misdiagnosis with Parkinson disease (PD) and within the entities is common, given the absence of reliable biomarkers. However a correct diagnosis is not only important in clinical practice, but also crucial for any trial attempting to identify biomarkers or new treatments. METHODS: Consecutive patients, who were referred to our tertiary center with a diagnosis of a particular AP were included and the medical records were reviewed retrospectively. We applied each set of current diagnostic research criteria to the respective cohort to see which features fit in and if there are any additional atypical features "outside" the classic definition. RESULTS: Sixty-nine patients were recruited between January 2013 and May 2015 clinically presenting with one of the following phenotypes: 14 MSA, 24 PSP, 19 CBS and 12 DLB. Up to 49% showed additional "atypical" features and approximately 10% eventually received an alternative diagnosis, in half of whom this being based on genetic testing. CONCLUSIONS: In a subset of our patients, despite the final diagnosis of an AP being maintained, there were additional "atypical" features. It remains to be seen if these reflect the clinical heterogeneity of APs, or should prompt a search for an alternative diagnosis. The search for biomarkers is more likely to be successful in homogenous groups of "typical" patients, hence the importance of recognizing "atypical" features.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Aged - administration & dosage
- Cohort Studies - administration & dosage
- Diagnosis, Differential - administration & dosage
- Female - administration & dosage
- Humans - administration & dosage
- Lewy Body Disease - diagnosis, genetics
- Male - administration & dosage
- Middle Aged - administration & dosage
- Multiple System Atrophy - diagnosis, genetics
- Parkinsonian Disorders - diagnosis, genetics
- Supranuclear Palsy, Progressive - diagnosis, genetics
- Find related publications in this database (Keywords)
- Atypical parkinsonism
- Multiple system atrophy
- Progressive supranuclear palsy
- Corticobasal degeneration
- Dementia with lewy bodies
- Diagnostic research criteria
- AP-Phenocopies